Skip to main content

Rebecca Herzog

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Rebecca Herzog

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.

Related professionals

Ana Lain Fernandez

Ana Lain Fernandez

Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Andrea Nieto I Brocal

Andrea Nieto I Brocal

Medium Grade Technician
Human Resources Directorate
Read more
Jose Maria  Zuazo  Morquecho

Jose Maria Zuazo Morquecho

Liver Diseases
Read more
Angel Michael Ortiz Zúñiga

Angel Michael Ortiz Zúñiga

Predoctoral researcher
Diabetes and Metabolism
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.